Biomaterial Database

Response to recombinant human erythropoietin (rHu-Epo) in a patient with chronic renal failure and myelomonocytic leukaemia. 2001

F Salvati, and M Liani, and M Bonomini

UI	MeSH Term	Description	Entries
D007676	Kidney Failure, Chronic	The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297	Male		Males
D011994	Recombinant Proteins	Proteins prepared by recombinant DNA technology.	Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001853	Bone Marrow	The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.	Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004921	Erythropoietin	Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D000740	Anemia	A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.	Anemias
D015477	Leukemia, Myelomonocytic, Chronic	A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.	Myelomonocytic Leukemia, Chronic,Chronic Myelomonocytic Leukemia,Chronic Myelomonocytic Leukemias,Leukemia, Chronic Myelomonocytic,Leukemias, Chronic Myelomonocytic,Myelomonocytic Leukemias, Chronic

Related Publications

F Salvati, and M Liani, and M Bonomini

[Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO].

January 1996, Przeglad lekarski,

F Salvati, and M Liani, and M Bonomini

[Hemostatic changes associated with recombinant human erythropoietin (rHu Epo) treatment].

January 1991, Acta medica portuguesa,

F Salvati, and M Liani, and M Bonomini

Renal failure in a patient with chronic myelomonocytic leukaemia.

July 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

F Salvati, and M Liani, and M Bonomini

[The influence of recombinant human erythropoietin (rHu-EPO) on circadian rhythm of prolactin secretion in patients with chronic renal failure treated with hemodialysis].

January 1995, Polskie Archiwum Medycyny Wewnetrznej,

F Salvati, and M Liani, and M Bonomini

Response to erythropoietin in chronic myelomonocytic leukaemia.

August 2001, Internal medicine journal,

F Salvati, and M Liani, and M Bonomini

Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma.

June 1995, Annals of hematology,

F Salvati, and M Liani, and M Bonomini

[The effect of recombinant human erythropoietin (rHu-EPO) on the autonomic nervous system in patients hemodialyzed for chronic kidney failure].

January 1997, Polskie Archiwum Medycyny Wewnetrznej,